Advanced search
Publication Cover
Critical Reviews in Toxicology Volume 31, 2001 - Issue 1
Submit an article Journal homepage
2,591
Views
524
CrossRef citations to date
0
Altmetric
Research Article

Paracetamol (Acetaminophen)-Induced Toxicity: Molecular and Biochemical Mechanisms, Analogues and Protective Approaches

Jos G. M. Bessems Leiden/Amsterdam Center for Drug Research, Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
&
Nico P. E. Vermeulen Leiden/Amsterdam Center for Drug Research, Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
Pages 55-138 | Published online: 29 Sep 2008

REFERENCES

  • Aboul-Enein H.Y., Hassan M.M.A., Jado A.I. and Salah El- Din Rashed M. (1982) Analgesic activity of some fluorinated derivatives of acetanilide. Drugs in Ex- perimental and Clinical Research VIII:619–623.
  • Adamson G.M. and Harman A.W. (1989) A role for the glutathione peroxidase/reductase enzyme system in the protection from paracetamol toxicity in isolated mouse hepatocytes. Biochemical Pharmacology 38:3323–3330.
  • Adamson G.M. and Harman A.W. (1993) Oxidative stress in cultured hepatocytes exposed to acetaminophen. Bio- chemical Pharmacology 45:2289–2294.
  • Al-Mustafa Z.H., Al-Ali A.K., Qaw F.S. and Abdul-Cader Z. (1997) Cimetidine enhances the hepatoprotective action of N-acetylcysteine in mice treated with toxic doses of paracetamol. Toxicology 121:223–228.
  • Albano E., Poli G., Chiarpotto E., Biasi F. and Dianzani M.U. (1983) Paracetamol-stimulated lipid peroxidation in isolated rat and mouse hepatocytes. Chemico-Bio- logical Interactions 47:249–263.
  • Albano E., Rundgren M., Harvison P.J., Nelson S.D. and Moldeus P. (1985) Mechanisms of N-acetyl-p-benzo- quinone imine cytotoxicity. Molecular Pharmacology 28:306–311.
  • Alexidis A.N., Commandeur J.N.M., Rekka E.A., Groot E., Kourounakis P.N. and Vermeulen N.P.E. (1996) Novel piperidine derivatives - inhibitory properties towards cytochrome P450 isoforms, and cytoprotective and cytotoxic characteristics. Environmental Toxicology & Pharmacology 1:81–88.
  • Anonymous (1966) Werkwijze ter bereiding van farmaceutisch werkzame verbindingen, alsmede van farmaceutische preparaten die deze verbindingen bevatten, en vormstukken verkregen uit deze farmaceutische preparaten. Patent 6603932, 28th Sep- tember 1966, pp 1–18, Octrooiraad, Nederland. Aspro- Nicholas, Ltd. London, England.
  • Anundi I., Lähteenmäki T., Rundgren M., Moldeus P. and Lindros K.O. (1993) Zonation of acetaminophen me- tabolism and cytochrome P450 2E1–mediated toxic- ity studied in isolated periportal and perivenous hepa- tocytes. Biochemical Pharmacology 45:1251–1259.
  • Axworthy D.B., Hoffmann K.J., Streeter A.J., Calleman C.J., Pascoe G.A. and Baillie T.A. (1988) Covalent binding of acetaminophen to mouse hemoglobin. Identifica- tion of major and minor adducts formed in vivo and implications for the nature of the arylating metabo- lites. Chemico-Biological Interactions 68:99–116.
  • Baldew G.S., Boymans A.P., Mol J.G.J. and Vermeulen N.P.E. (1992) The influence of ebselen on the toxicity of cisplatin in LLC-PK1 cells. Biochemical Pharma- cology 44:382–387.
  • Bansal M.P., Mukhopadhyay T., Scott J., Cool R.G., Mukhopadhyay R. and Medina D. (1990) DNA se- quencing of a mouse liver protein that binds selenium: implications for selenium’s mechanism of action in cancer prevention. Carcinogenesis 1:2071–2073.
  • Barnard S., Kelly D.F., Storr R.C. and Park B.K. (1993a) The effect of fluorine substitution on the hepatotoxic- ity and metabolism of paracetamol in the mouse. Bio- chemical Pharmacology 46:841–849.
  • Barnard S., Storr R.C., O’Neill P.M. and Park B.K. (1993b) The effect of fluorine substitution on the physico- chemical properties and the analgesic activity of paracetamol. Journal of Pharmacy & Pharmacology 45:736–744.
  • Bartolone J.B., Beierschmitt W.P., Birge R.B., Hart S.G., Wyand S., Cohen S.D. and Khairallah E.A. (1989) Selective acetaminophen metabolite binding to he- patic and extrahepatic proteins: An in vivo and in vitro analysis. Toxicology & Applied Pharmacology 99:240– 249.
  • Bartolone J.B., Birge R.B., Bulera S.J., Bruno M.K., Nishanian E.V., Cohen S.D. and Khairallah E.A. (1992) Purification, antibody production, and partial amino acid sequence of the 58–kDa acetaminophen binding liver proteins. Toxicology & Applied Phar- macology 113:19–29.
  • Bartolone J.B., Birge R.B., Sparks K., Cohen S.D. and Khairallah E.A. (1988) Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochemical Pharmacology 37:4763– 4774.
  • Bast A. (1986) Is formation of reactive oxygen by cyto- chrome P-450 perilous and predictable? Trends in Pharmacological Sciences July.
  • Bergman K., Muller L. and Teigen S.W. (1996) Series: current issues in mutagenesis and carcinogenesis, No.65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. Mutation Research 349:263–288.
  • Bertelli A., Bertelli A.A., Giovannini L., Mian M. and Spaggiari P. (1990) Protective action of coenzyme A on paracetamol-induced tissue depletion of glutathione. International Journal of Tissue Reactions 12:353– 358.
  • Berthou F., Guillois B., Riche C., Dreano Y., Jacqz-Aigrain E. and Beaune P.H. (1992) Interspecies variations in caffein metabolism related to cytochrome P4501A enzymes. Xenobiotica 22:671–680.
  • Bessems J.G.M., De Groot M.J., Baede E.J., Te Koppele J.M. and Vermeulen N.P.E. (1998) Hydrogen atom abstraction of 3,5–disubstituted analogues of paracetamol by horseradish peroxidase and cytochrome P450. Xenobiotica 28:855–875.
  • Bessems J.G.M., Gaisser H.D., Te Koppele J.M., Van Bennekom W.P., Commandeur J.N.M. and Vermeulen N.P.E. (1995) 3,5–Disubstituted analogues of paracetamol. Synthesis, analgesic activity and cyto- toxicity. Chemico-Biological Interactions 98: 237–250.Bessems J.G.M., Te Koppele J.M., Van Dijk P.A., Van Stee L.L.P., Commandeur J.N.M. and Vermeulen N.P.E. (1996) Rat liver microsomal cytochrome P450–de- pendent oxidation of 3,5–disubstituted analogues of paracetamol. Xenobiotica 26:647–666.
  • Bessems J.G.M., Van Stee L.L.P., Commandeur J.N.M., Groot E.J. and Vermeulen N.P.E. (1997) Cytotoxicity of paracetamol and 3,5–dihalogenated analogues: Role of cytochrome P-450 and formation of GSH conju- gates and protein adducts. Toxicology in Vitro 11:9– 19.
  • Betowski L.D., Korfmacher W.A., Lay J.O., Potter D.W. and Hinson J.A. (1987) Direct analysis of rat bile for acetaminophen and two of its conjugated metabolites via thermospray liquid chromatography/mass spec- trometry. Biomedical and Environmental Mass Spec- trometry 14:705–709.
  • Birge R.B., Bartolone J.B., Cohen S.D., Khairallah E.A. and Smolin L.A. (1991a) A comparison of proteins S- thiolated by glutathione to those arylated by acetami- nophen. Biochemical Pharmacology 42:S197–207.
  • Birge R.B., Bartolone J.B., Hart S.G., Nishanian E.V., Tyson C.A., Khairallah E.A. and Cohen S.D. (1990) Ac- etaminophen hepatotoxicity: Correspondence of se- lective protein arylation in human and mouse liver in vitro, in culture, and in vivo. <i>Toxicology & Applied Pharmacology105:472–482.
  • Birge R.B., Bartolone J.B., McCann D.J., Mangold J.B., Cohen S.D. and Khairallah E.A. (1989) Selective pro- tein arylation by acetaminophen and 2,6– dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice. Relation- ship to cytotoxicity. Biochemical Pharmacology 38:4429–4438.
  • Birge R.B., Bartolone J.B., Nishanian E.V., Bruno M.K., Mangold J.B., Cohen S.D. and Khairallah E.A. (1988) Dissociation of covalent binding from the oxidative effects of acetaminophen. Studies using dimethylated acetaminophen derivatives. Biochemical Pharmacol- ogy 37:3383–3393.
  • Birge R.B., Bulera S.J., Bartolone J.B., Ginsberg G.L., Cohen S.D. and Khairallah E.A. (1991b) The arylation of microsomal membrane proteins by acetaminophen is associated with the release of a 44 kDa acetaminophen- binding mouse liver protein complex into the cytosol. Toxicology & Applied Pharmacology 109:443–454.
  • Björck S., Svalander C.T. and Aurell M. (1988) Acute renal failure after analgesic drugs including paracetamol (acetaminophen). Nephron 49:45–53.
  • Blantz R.C. (1996) Acetaminophen: acute and chronic ef- fects on renal function. American Journal of Kidney Diseases 28:S3–6.
  • Blazka M.E., Germolec D.R., Simeonova P., Bruccoleri A., Pennypacker K.R. and Luster M.I. (1996) Acetami- nophen-induced hepatotoxicity is associated with early changes in NF-kappa-B and NF-IL6 DNA binding activity. Journal of Inflammation 47:138–150.
  • Blazka M.E., Wilmer J.L., Holladay S.D., Wilson R.E. and Luster M.I. (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicology & Ap- plied Pharmacology 133:43–52.
  • Boulares H.A., Giardina C., Navarro C.L., Khairallah E.A. and Cohen S.D. (1999) Modulation of serum growth factor signal transduction in Hepa 1–6 cells by ac- etaminophen: An inhibition of c-myc expression, NF- KB activation, and Raf-1 kinase activity. Toxicologi- cal Sciences 48:264–274.
  • Bray G.P., Tredger J.M. and Williams R. (1992) S- adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology 15:297–301.
  • Brunborg G., Holme J.A. and Hongslo J.K. (1995) Inhibitory effects of paracetamol on DNA repair in mammalian cells. Mutation Research: Genetic Toxicology 342:157–170.
  • Bruno M.K., Cohen S.D. and Khairallah E.A. (1992) Selec- tive alterations in the patterns of newly synthesized proteins by acetaminophen and its dimethylated ana- logues in primary cultures of mouse hepatocytes. Toxicology and Applied Pharmacology 112: 282–290.Bruno M.K., Khairallah E.A. and Cohen S.D. (1998) Inhibi- tion of protein phosphatase activity and changes in protein phosphorylation following acetaminophen exposure in cultured mouse hepatocytes. Toxicology and Applied Pharmacology 153:119–132.
  • Bulera S.J., Birge R.B., Cohen S.D. and Khairallah E.A. (1995) Identification of the mouse liver 44–kDa ac- etaminophen-binding protein as a subunit of glutamine synthetase. Toxicology & Applied Pharmacology 134:313–320.
  • Burcham P.C. and Harman A.W. (1990) Mitochondrial dys- function in paracetamol hepatotoxicity: in vitro stud- ies in isolated mouse hepatocytes. Toxicology Letters 50:37–48.
  • Burcham P.C. and Harman A.W. (1991) Acetaminophen toxicity results in site-specific mitochondrial damage isolated mouse hepatocytes. The Journal of Biologi- cal Chemistry 266:5049–5054.
  • Burchell B. and Coughtrie M.W.H. (1997) Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation. Environmental Health Perspectives 105:739–747.
  • Burk R.F., Hill K.E., Hunt R.W., Jr. and Martin A.E. (1990) Isoniazid potentiation of acetaminophen hepatotoxic- ity in the rat and 4–methylpyrazole inhibition of it. Research Communications in Chemical Pathology & Pharmacology 69:115–118.
  • Calder I.C., Hart S.J., Healey K. and Ham K.N. (1981) N- hydroxyacetaminophen: A postulated toxic metabo- lite of acetaminophen. Journal of Medicinal Chemis- try 24:988–993.
  • Carter E.A. (1987) Enhanced acetaminophen toxicity associ- ated with prior alcohol consumption in mice: preven- tion by N-acetylcysteine. Alcohol 4:69–71.
  • Chamulitrat W., Cohen M.S. and Mason R.P. (1991) Free radical formation from organic hydroperoxides in iso- lated human polymorphonuclear neutrophils. Free Radical Biology & Medicine 11:439–445.
  • Chanda S., Mangipudy R.S., Warbritton A., Bucci T.J. and Mehendale H.M. (1995) Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology 21:477–486.
  • Chanda S. and Mehendale H.M. (1996a) Hepatic cell divi- sion and tissue repair: A key to survival after liver injury. Molecular Medicine Today 2:82–89.
  • Chanda S. and Mehendale H.M. (1996b) Role of nutrition in the survival after hepatotoxic injury. Toxicology 111:163–178.
  • Chen L., Mohr S.N. and Yang C.S. (1996) Decrease of plasma and urinary oxidative metabolites of acetami- nophen after consumption of watercress by human volunteers. Clinical Pharmacology & Therapeutics 60:651–660.
  • Chen W., Koenigs L.L., Thompson S.J., Peter R.M., Rettie A.E., Trager W.F. and Nelson S.D. (1998) Oxidation of acetaminophen to its toxic quinone imine and non- toxic catechol metabolites by baculovirus-expressed and purified human cytochromes 2E1 and 2A6. Chemi- cal Research in Toxicology 11:295–301.
  • Chengelis C.P., Dodd D.C., Means J.R. and Kotsonis F.N. (1986) Protection by zinc against acetaminophen in- duced hepatotoxicity in mice. Fundamental & Ap- plied Toxicology 6:278–284.
  • Chiba M. and Pang K.S. (1995) Glutathione depletion kinet- ics with acetaminophen. A simulation study. Drug Metabolism & Disposition 23:622–630.
  • Cobden I., Record C.O., Ward M.K. and Kerr B.N.S. (1982) Paracetamol-induced acute renal failure in the ab- sence of fulminant liver damage. British Medical Jour- nal 284:21–22.
  • Cohen S.D., Pumford N.R., Khairallah E.A., Boekelheide K., Pohl L.R., Amouzadeh H.R. and Hinson J.A. (1997) Selective protein covalent binding and target organ toxicity. Toxicology & Applied Pharmacology 143:1– 12.
  • Coles B., Wilson I., Wardman P., Hinson J.A., Nelson S.D. and Ketterer B. (1988) The spontaneous and enzy- matic reaction of N-acetyl-p-benzoquinonimine with glutathion: A stopped-flow kinetic study. Archives of Biochemistry and Biophysics 264:253–260.
  • Commandeur J.N.M., Stijntjes G.J. and Vermeulen N.P.E. (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacological Reviews 47:271–330.
  • Corbett M.D., Corbett B.R., Hannothiaux M.H. and Quintana S.J. (1989) Metabolic activation and nucleic acid bind- ing of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes. Chemi- cal Research in Toxicology 2:260–266.
  • Corbett M.D., Corbett B.R., Hannothiaux M.H. and Quintana S.J. (1992) The covalent binding of acetaminophen to cellular nucleic acids as the result of the respiratory burst of neutrophils derived from the HL-60 cell line. Toxicology & Applied Pharmacology 113:80–86.
  • Corcoran G.B., Bauer J.A. and Lau T.W. (1988) Immediate rise in intracellular calcium and glycogen phosphory- lase a activities upon acetaminophen covalent binding leading to hepatotoxicity in mice. Toxicology 50:157– 167.
  • Corcoran G.B., Chung S.J. and Salazar D.E. (1987a) Early inhibition of the Na+/K+-ATPase ion pump during acetaminophen-induced hepatotoxicity in rat. Bio- chemical & Biophysical Research Communications 149:203–207.
  • Corcoran G.B., Mitchell J.R., Vaishnav Y.N. and Horning E.C. (1980) Evidence that acetaminophen and N- hydroxyacetaminophen form a common arylating in- termediate, N-acetyl-p-benzoquinoneimine. Molecu- lar Pharmacology 18:536–542.
  • Corcoran G.B., Todd E.L., Racz W.J., Hughes H., Smith C.V. and Mitchell J.R. (1985) Effects of N- acetylcysteine on the disposition and metabolism of acetaminophen in mice. Journal of Pharmacology & Experimental Therapeutics 232:857–863.
  • Corcoran G.B. and Wong B.K. (1986) Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl- D-cysteine in mice. Journal of Pharmacology & Ex- perimental Therapeutics 238:54–61.
  • Corcoran G.B. and Wong B.K. (1987) Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat. Journal of Pharmacology & Experimen- tal Therapeutics 241:921–927.
  • Corcoran G.B., Wong B.K. and Neese B.L. (1987b) Early sustained rise in total liver calcium during acetami- nophen hepatotoxicity in mice. Research Communi- cations in Chemical Pathology & Pharmacology 58:291–305.
  • Cotgreave I.A., Morgenstern R., Engman L. and Ahokas J. (1992) Characterisation and quantitation of a selenol intermediate in the reaction of ebselen with thiols. Chemico-Biological Interactions 84:69–76.
  • Cramer D.W., Harlow B.L., Titus-Ernstoff L., Bohlke K., Welch W.R. and Greenberg E.R. (1998) Over-the- counter analgesics and risk of ovarian cancer. Lancet 351:104–107.
  • Critchley J.A., Nimmo G.R., Gregson C.A., Woolhouse N.M. and Prescott L.F. (1986) Inter-subject and ethnic dif- ferences in paracetamol metabolism. British Journal of Clinical Pharmacology 22:649–657.
  • Dahlin D.C., Miwa G.T., Lu A.Y. and Nelson S.D. (1984) N- acetyl-p-benzoquinone imine: A cytochrome P-450– mediated oxidation product of acetaminophen. Pro- ceedings of the National Academy of Sciences of the United States of America 81:1327–1331.
  • Dai Y. and Cederbaum A.I. (1995) Cytotoxicity of acetami- nophen in human cytochrome P4502E1–transfected HepG2 cells. Journal of Pharmacology & Experimen- tal Therapeutics 273:1497–1505.
  • De Morais S.M., Uetrecht J.P. and Wells P.G. (1992) De- creased glucuronidation and increased bioactivation of acetaminophen in Gilbert’s syndrome. Gastroen- terology 102:577–586.
  • De Vries J. (1981) Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilate: oxygenation or electron transfer? Biochemi- cal Pharmacology 30:399–402.
  • De Vries J., De Jong J., Lock F.M., Van Bree L., Mullink H. and Veldhuizen R.W. (1984) Protection against paracetamol-induced hepatotoxicity by acetylsalicylic acid in rats. Toxicology 30:297–304.
  • De Vries J., Jansen J.D., Kroese E.D., Van Bree L. and Van Ginneken C.A. (1981) Protection against paracetamol-induced glutathione depletion follow- ing a paracetamol-acetylsalicylic acid mixture or benorilate in phenobarbital-treated rats. Toxicology Letters 9:345–347.
  • Dearden J.C., O’Hara J.H. and Townend M.S. (1980) A double-peaked quantitative structure-activity relation- ship (QSAR) in a series of paracetamol derivatives. Journal of Pharmacy and Pharmacology 32:102P.
  • Devalia J.L., Ogilvie R.C. and McLean A.E. (1982) Disso- ciation of cell death from covalent binding of paracetamol by flavones in a hepatocyte system. Bio- chemical Pharmacology 31:3745–3749.
  • Dietze E.C., Schäfer A., Omichinski J.G. and Nelson S.D. (1997) Inactivation of glyceraldehyde-3–phosphate dehydrogenase by a reactive metabolite of acetami- nophen and mass spectral characterization of an arylated active site peptide. Chemical Research in Toxicology 10:1097–1103.
  • Donatus I.A., Sardjoko and Vermeulen N.P. (1990) Cyto- toxic and cytoprotective activities of curcumin. Ef- fects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepato- cytes. Biochemical Pharmacology 39:1869–1875.
  • Donnelly P.J., Walker R.M. and Racz W.J. (1994) Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Archives of Toxicology 68:110–118.
  • Drew R. and Miners J.O. (1984) The effects of buthionine sulfoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochemical Pharma- cology 33:2989–2994.
  • Eastmond D.A. (1993) Induction of micronuclei and aneup- loidy by the quinone-forming agents benzene and o- phenylphenol. Toxicology Letters 67:105–118.
  • Eguia L. and Materson B.J. (1997) Acetaminophen-related renal failure without fulminant liver failure. Pharma- cotherapy 17:363–370.
  • Eliasson E., Mkrtchian S. and Ingelman-Sundberg M. (1992) Hormone- and substrate-regulated intracellular degra- dation of cytochrome P450 (2E1) involving MgATP- activated rapid proteolysis in the endoplasmic reticu- lum membranes. Journal of Biological Chemistry 267:15765–15769.
  • Eling T.E. and Curtis J.F. (1992) Xenobiotic metabolism by prostaglandin-H synthase. Pharmacology & Thera- peutics 53:261–273.
  • Emeigh Hart S.G., Beierschmitt W.P., Bartolone J.B., Wyand D.S., Khairallah E.A. and Cohen S.D. (1991a) Evi- dence against deacetylation and for cytochrome P450– mediated activation in acetaminophen-induced neph- rotoxicity in the CD-1 mouse. Toxicology & Applied Pharmacology 107:1–15.
  • Emeigh Hart S.G., Birge R.B., Cartun R.W., Tyson C.A., Dabbs J.E., Nishanian E.V., Wyand D.S., Khairallah E.A. and Cohen S.D. (1991b) In vivo and in vitro evidence for in situ activation and selective cova- lent binding of acetaminophen (APAP) in mouse kidney. Advances in Experimental Medicine & Bi- ology (Biological Reactive Intermediates IV) 283:711–716.
  • Emeigh Hart S.G., Wyand D.S., Khairallah E.A. and Cohen S.D. (1996) Acetaminophen nephrotoxicity in the CD- 1 mouse. II. Protection by probenecid and AT-125 without diminution of renal covalent binding. Toxi- cology & Applied Pharmacology 136:161–169.
  • Fayz S., Cherry W.F., Dawson J.R., Mulder G.J. and Pang K.S. (1984) Inhibition of acetaminophen sulfation by 2,6–dichloro-4–nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation. Drug Metabolism & Disposition 12:323–329.
  • Fernando C.R., Calder I.C. and Ham K.N. (1980) Studies on the mechanism of toxicity of acetaminophen. Synthe- sis and reactions of N-acetyl-2,6–dimethyl- and N- acetyl-3,5–dimethyl-p-benzoquinone imines. Journal of Medicinal Chemistry 23:1153–1158.
  • Fischer L.J., Green M.D. and Harman A.W. (1985a) Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice. Drug Metabolism & Dis- position 13:121–126.
  • Fischer V. and Mason R.P. (1984) Stable free radical and benzoquinone imine metabolites of an acetaminophen analogue. Journal of Biological Chemistry 259:10284– 10288.
  • Fischer V., West P.R., Harman L.S. and Mason R.P. (1985b) Free-radical metabolites of acetaminophen and a dimethylated derivative. Environmental Health Per- spectives 64:127–137.
  • Fischer V., West P.R., Nelson S.D., Harvison P.J. and Ma- son R.P. (1985c) Formation of 4-aminophenoxyl free radical from the acetaminophen metabolite N-acetyl- p-benzoquinone imine. Journal of Biological Chemis- try 260:11446–11450.
  • Fischereder M. and Jaffe J.P. (1994) Thrombocytopenia fol- lowing acute acetaminophen overdose. American Jour- nal of Hematology 45:258–259.
  • Flaks A. and Flaks B. (1983) Induction of liver cell tumours in IF mice by paracetamol. Carcinogenesis 4:363– 368.
  • Flaks B., Flaks A. and Shaw A.P. (1985) Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure. Acta Pathologica, Microbiologica, et Immunologica Scandinavica - Sec- tion A, Pathology 93:367–377.
  • Flower R.J. and Vane J.R. (1972) Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4–acetamidophenol). Nature 240:410– 411.
  • Forte A.J., Wilson J.M., Slattery J.T. and Nelson S.D. (1984) The formation and toxicity of catechol metabolites of acetaminophen in mice. Drug Metabolism & Disposi- tion 12:484–491.
  • Fouse B.L. and Hodgson E. (1987) Effect of chlordecone and mirex on the acute hepatotoxicity of acetami- nophen in mice. General Pharmacology 18: 623–630.Fowler L.M., Moore R.B., Foster J.R. and Lock E.A. (1991) Nephrotoxicity of 4–aminophenol glutathione conjugate. Human & Experimental Toxicology 10: 451–459.Galinsky R.E. (1986) Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat. Journal of Pharmacology & Experimental Therapeutics 236:133–139.
  • Gardner C.R., D.E. H., Yang C.S., Thomas P.E., Zhang X.J., DeGeorge G.L., Laskin J.D. and Laskin D.L. (1998) Role of nitric oxide in acetaminophen-induced hepa- totoxicity in the rat. Hepatology 27:748–754.
  • Garrido A., Arancibia C., Campos R. and Valenzuela A. (1991) Acetaminophen does not induce oxidative stress in isolated rat hepatocytes: its probable antioxidant effect is potentiated by the flavonoid silybin. Pharma- cology & Toxicology 69:9–12.
  • Gemborys M.W. and Mudge G.H. (1981) Formation and disposition of the minor metabolites of acetaminophen in the hamster. Drug Metabolism & Disposition 9:340– 351.
  • Gerson R.J., Casini A., Gilfor D., Serroni A. and Farber J.L. (1985) Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochemical & Biophysical Research Communications 126:1129– 1137.
  • Gibson J.D., Pumford N.R., Samokyszyn V.M. and Hinson J.A. (1996) Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chemical Research in Toxicology 9: 580–585.Goeptar A.R., Scheerens H. and Vermeulen N.P.E. (1995) Oxygen and xenobiotic reductase activities of cyto- chrome P450. Critical Reviews in Toxicology 25:25–65.
  • Goeptar A.R., Te Koppele J.M., Van Maanen J.M., Zoetemelk C.E. and Vermeulen N.P.E. (1992) One-electron re- ductive bioactivation of 2,3,5,6–tetramethylbenzo- quinone by cytochrome P450. Biochemical Pharma- cology 43:343–352.
  • Gregus Z., Madhu C. and Klaassen C.D. (1988) Species variation in toxication and detoxication of acetami- nophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. Jour- nal of Pharmacology & Experimental Therapeutics 244:91–99.
  • Grewal K.K. and Racz W.J. (1993) Intracellular calcium disruption as a secondary event in acetaminophen- induced hepatotoxicity. Canadian Journal of Physiol- ogy & Pharmacology 71:26–33.
  • Guengerich F.P. (1995) Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. American Journal of Clinical Nutrition 61: 651S-658S.Gupta S., Rogers L.K., Taylor S.K. and Smith C.V. (1997) Inhibition of carbamyl phosphate synthethase-I and glutamine synthetase by hepatotoxic doses of acetami- nophen in mice. Toxicology and Applied Pharmacology 146:317–327.
  • Haenen G.R.M.M., de Rooij B.M., Vermeulen N.P.E. and Bast A. (1989) Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen. Molecular Pharmacology 37:412–422.
  • Halmes N.C., Hinson J.A., Martin B.M. and Pumford N.R. (1996) Glutamate dehydrogenase covalently binds to a reactive metabolite of acetaminophen. Chem Res Toxicol 9:541–546.
  • Halmes N.C., Samokyszyn V.M., Hinton T.W., Hinson J.A. and Pumford N.R. (1998) The acetaminophen regioisomer 3’-hydroxyacetanilide inhibits and co- valently binds to cytochrome P450 2E1. Toxicology Letters 94:65–71.
  • Hamilton M. and Kissinger P.T. (1986) The metabolism of 2– and 3–hydroxyacetanilide. Drug Metabolism and Disposition 14:5–12.
  • Harman A.W. (1985) The effectiveness of antioxidants in reducing paracetamol-induced damage subsequent to paracetamol activation. Research Communications in Chemical Pathology & Pharmacology 49:215–228.
  • Harman A.W., Adamson G.M. and Shaw S.G. (1992) Pro- tection from oxidative damage in mouse liver cells. Toxicology Letters 64–65:581–587.
  • Harman A.W. and Fischer L.J. (1983) Hamster hepatocytes in culture as a model for acetaminophen toxicity: Studies with inhibitors of drug metabolism. Toxicol- ogy and Applied Pharmacology 71:330–341.
  • Harman A.W., Kyle M.E., Serroni A. and Farber J.L. (1991) The killing of cultured hepatocytes by N-acetyl-p- benzoquinone imine (NAPQI) as a model of the cyto- toxicity of acetaminophen. Biochemical Pharmacol- ogy 41:1111–1117.
  • Harnagea-Theophilus E., Miller M.R. and Rao N. (1999) Positional isomers of acetaminophen differentially induce proliferation of cultured breast cancer cells. Toxicology Letters 104:11–18.
  • Hart S., Healey K., Small M. and Calder I. (1982) 3– Thiomethylparacetamol sulfate and glucuronide: me- tabolites of paracetamol and N-hydroxyparacetamol. Xenobiotica 12:381–386.
  • Harvison P.J., Egan R.W., Gale P.H., Christian G.D., Hill B.S. and Nelson S.D. (1988a) Acetaminophen and analogs as cosubstrates and inhibitors of prostaglan- din H synthase. Chemico-Biological Interactions 64:251–266.
  • Harvison P.J., Egan R.W., Gale P.H. and Nelson S.D. (1986a) Acetaminophen as a cosubstrate and inhibitor of pros- taglandin H synthase. Advances in Experimental Medi- cine and Biology (Biological Reactive Intermediates III) 197:739–747.
  • Harvison P.J., Forte A.J. and Nelson S.D. (1986b) Compara- tive toxicities and analgesic activities of three monomethylated analogues of acetaminophen. Jour- nal of Medicinal Chemistry 29:1737–1743.
  • Harvison P.J., Guengerich F.P., Rashed M.S. and Nelson S.D. (1988b) Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen. Chemical Research in Toxicology 1:47–52.
  • Hinchman C.A. and Ballatori N. (1990) Glutathione-degrad- ing capacities of liver and kidney in different species. Biochemical Pharmacology 40:1131–1135.
  • Hinson J.A. (1980) Biochemical toxicology of acetami- nophen, In: Reviews in Biochemical Toxicology, ed- ited by E Hodgson, JR Bend and RM Philpot (Amsterdam: Elsevier), pp 103–129.
  • Hinson J.A., Monks T.J., Hong M., Highet R.J. and Pohl L.R. (1982) 3–(Glutathion-S-yl)acetaminophen: A bil- iary metabolite of acetaminophen. Drug Metabolism & Disposition 10:47–50.
  • Hinson J.A., Pike S.L., Pumford N.R. and Mayeux P.R. (1998) Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetminophen in mice. Chemical Research in Toxi- cology 11:604–607.
  • Hinson J.A., Pohl L.R. and Gilette J.R. (1979) N- Hydroxyacetaminophen: A microsomal metabolite of N-hydroxyphenacetin but apparently not of acetami- nophen. Life Sciences 24:2133–2138.
  • Hinson J.A., Pohl L.R., Monks T.J. and Gillette J.R. (1981) Acetaminophen-induced hepatotoxicity. Life Sciences 29:107–116.
  • Hinson J.A., Pohl L.R., Monks T.J., Gillette J.R. and Guengerich F.P. (1980) 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metabolism & Disposition 8:289– 294.
  • Hinson J.A., Pumford N.R. and Roberts D.W. (1995) Mecha- nisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metabolism Reviews 27:73–92.
  • Hinson J.A., Roberts D.W., Benson R.W., Dalhoff K., Loft S. and Poulsen H.E. (1990) Mechanism of paracetamol toxicity [letter]. Lancet 335:732.
  • Hinson J.A., Roberts D.W., Halmes N.C., Gibson J.D. and Pumford N.R. (1996) Immunochemical detection of drug-protein adducts in acetaminophen hepatotoxic- ity. Advances in Experimental Medicine and Biology (Biological Reactive Intermediates V) 387:47–55.
  • Hoffmann K.J., Axworthy D.B. and Baillie T.A. (1990) Mechanistic studies on the metabolic activation of acetaminophen in vivo. Chemical Research in Toxi- cology 3:204–211.
  • Hoffmann K.J., Streeter A.J., Axworthy D.B. and Baillie T.A. (1985a) Identification of the major covalent ad- duct formedin vitro and in vivo between acetami- nophen and mouse liver proteins. Molecular Pharma- cology 27:566–573.
  • Hoffmann K.J., Streeter A.J., Axworthy D.B. and Baillie T.A. (1985b) Structural characterization of the major covalent adduct formed in vitro between acetami- nophen and bovine serum albumin. Chemico-Biologi- cal Interactions 53:155–172.
  • Hoivik D.J., Fisher R.L., Brendel K., Gandolfi A.J., Khairallah E.A. and Cohen S.D. (1996a) Protein arylation pre- cedes acetaminophen toxicity in a dynamic organ slice culture of mouse kidney. Fundamental & Applied Toxicology 34:99–104.
  • Hoivik D.J., Manautou J.E., Tveit A., Hart S.G., Khairallah E.A. and Cohen S.D. (1995) Gender-related differ- ences in susceptibility to acetaminophen-induced pro- tein arylation and nephrotoxicity in the CD-1 mouse. Toxicology & Applied Pharmacology 130:257–271.
  • Hoivik D.J., Manautou J.E., Tveit A., Mankowski D.C., Khairallah E.A. and Cohen S.D. (1996b) Evidence suggesting the 58–kDa acetaminophen binding pro- tein is a preferential target for acetaminophen electrophile. Fundamental & Applied Toxicology 32:79–86.
  • Holme J.A., Hongslo J.K., Bjorge C. and Nelson S.D. (1991) Comparative cytotoxic effects of acetaminophen (N- acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes. Biochemical Pharma- cology 42:1137–1142.
  • Holtzman J.L. (1995) The role of covalent binding to mi- crosomal proteins in the hepatotoxicity of acetami- nophen. Drug Metabolism Reviews 27:277–297.
  • Hong M., Cohen S.D. and Khairallah E.A. (1994) Translo- cation of the major cytosolic acetaminophen (APAP) protein adducts into the nucleus. Toxicologist 14:427 (Abstract 1691).
  • Hongslo J.K., Bjorge C., Schwarze P.E., Brogger A., Mann G., Thelander L. and Holme J.A. (1990) Paracetamo linhibits replicative DNA synthesis and induces sister chromatid exchange and chromosomal aberrations by inhibition of ribonucleotide reductase. Mutagenesis 5:475–480.
  • Hongslo J.K., Smith C.V., Brunborg G., Soderlund E.J. and Holme J.A. (1994) Genotoxicity of paracetamol in mice and rats. Mutagenesis 9:93–100.
  • Howie D., Adriaenssens P. and Prescott L.F. (1977) Paracetamol metabolism following overdosage: Ap- plication of high performance liquid chromatography. Journal of Pharmacy and Pharmacology 29:235–237.
  • Hu J.J., Lee M.J., Vapiwala M., Reuhl K., Thomas P.E. and Yang C.S. (1993) Sex-related differences in mouse renal metabolism and toxicity of acetaminophen. Toxi- cology & Applied Pharmacology 122:16–26.
  • Hu Y., Ingelman-Sundberg M. and Lindros K.O. (1995) Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starva- tion. Biochemical Pharmacology 50:155–161.
  • Hue D.P., Griffith K.L. and McLean A.E. (1985) Hepato- cytes in primary culture become susceptible to paracetamol injury after depletion of glutathione us- ing DL-buthionine-SR-sulfoximine (BSO). Biochemi- cal Pharmacology 34:4341–4344.
  • Hughes R.D., Gove C.D. and Williams R. (1991) Protective effects of propylene glycol, a solvent used pharma- ceutically, against paracetamol-induced liver injury in mice. Biochemical Pharmacology 42:710–713.
  • Ioannides C., Steele C.M. and Parke D.V. (1983) Species variation in the metabolic activation of paracetamol to toxic intermediates: role of cytochromes P-450 and P-448. Toxicology Letters 16:55–61.
  • Jaeschke H. (1990) Glutathione disulfide formation and oxi- dant stress during acetaminophen-induced hepatotox- icity in mice in vivo: the protective effect of allopu- rinol. Journal of Pharmacology & Experimental Therapeutics 255:935–941.
  • Jamba L., Nehru B., Medina D., Bansal M.P. and Sinha R. (1996) Isolation and identification of selenium-labeled proteins in the mouse kidney. Anticancer Research 16:1651–1657.
  • James R.C., Harbison R.D. and Roberts S.M. (1993) Phenyl- propanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism. Toxicology & Applied Pharmacology 118:159–168.
  • Jaw S. and Jeffery E.H. (1993) Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with vari- ous cytochrome P450 inducing agents. Biochemical Pharmacology 46:493–501.
  • Jeffery E.H., Arndt K. and Haschek W.M. (1991) The role of cytochrome P450IIE1 in bioactivation of acetami- nophen in diabetic and acetone-treated mice. Advances in Experimental Medicine & Biology (Biological Re- active Intermediates IV) 283:249–251.
  • Jeffery E.H. and Haschek W.M. (1988) Protection by dim- ethylsulfoxide against acetaminophen-induced hepatic, but not respiratory toxicity in the mouse. Toxicology & Applied Pharmacology 93:452–461.
  • Johansson I., Ekstrom G., Scholte B., Puzycki D., Jornvall H. and Ingelman-Sundberg M. (1988) Ethanol-, fast- ing-, and acetone-inducible cytochromes P-450 in rat liver: regulation and characteristics of enzymes be- longing to the IIB and IIE gene subfamilies. Biochem- istry 27:1925–1934.
  • Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R. and Brodie B.B. (1973) Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. Journal of Pharmacology and Experimental Thera- peutics 187:195–202.
  • Jones A.L. (1998) Mechanism of action and value of N- acetylcysteine in the treatment of early and late ac- etaminophen poisoning: A critical review. Clinical Toxicology 36:277–285.
  • Jörgensen L., Thomsen P. and Poulsen H.E. (1988) Disul- firam prevents acetaminophen hepatotoxicity in rats. Pharmacology & Toxicology 62:267–271.
  • Josephy P.D., Eling T.E. and Mason R.P. (1983) Oxidation of p-aminophenol catalyzed by horseradish peroxi- dase and prostaglandin synthase. Molecular Pharma- cology 23:461–466.
  • Kadri A., Fischer R. and Winteron M. (1988) Cimetidine and paracetamol hepatotoxicity. Human Toxicol 7:205.
  • Kalhorn T.F., Lee C.A., Slattery J.T. and Nelson S.D. (1990) Effect of methylxanthines on acetaminophen hepato- toxicity in various induction states. Journal of Phar- macology & Experimental Therapeutics 252: 112–116.Kamiyama T., Sato C., Liu J., Tajiri K., Miyakawa H. and Marumo F. (1993) Role of lipid peroxidation in ac- etaminophen-induced hepatotoxicity: comparison with carbon tetrachloride. Toxicology Letters 66:7–12.
  • Keller R.J. and Hinson J.A. (1991) Mechanism of acetami- nophen-stimulated NADPH oxidation catalyzed by the peroxidase-H2O2 system. Drug Metabolism and Disposition 19:184–187.
  • Ketterer B., Meyer D.J. and Clark G.C. (1988) Soluble glu- tathione transferase enzymes, In: Glutathione Conju- gation. Mechanisms and Biological Significance, ed- ited by H Sies and B Ketterer (London: Academic Press Limited), pp 86–87.
  • Khairallah E.A., Bruno M.K., Hong M. and Cohen S.D. (1995) Cellular consequences of protein adduct for- mation. Toxicologist 15:86.
  • Kleiner H.E., Jones T.W., Monks T.J. and Lau S.S. (1998) Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant fo quinol-thioether-mediated nephrotox- icity. Chemical Research in Toxicology 11:1291–1300.
  • Klos C., Koob M., Kramer C. and Dekant W. (1992) p- Aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates. Toxicology & Applied Phar- macology 115:98–106.
  • Knox J.H. and Jurand J. (1977) Determination of paracetamol and its metabolites in urine by high-performance liq- uid chromatography using reversed-phase bonded supports. Journal of Chromatography 142:651–670.
  • Koop D.R., Chernosky A. and Brass E.P. (1991) Identifica- tion and induction of cytochrome P450 2E1 in rat Kupffer cells. Journal of Pharmacology & Experi- mental Therapeutics 258:1072–1076.
  • Kostrubsky V.E., Lewis L.D., Wood S.G., Sinclair P.R., Wrighton S.A. and Sinclair J.F. (1997a) Effect of Taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: comparison to dexamethasone. Toxicology & Applied Pharmacol- ogy 142:79–86.
  • Kostrubsky V.E., Szakacs J.G., Jeffery E.H., Wood S.G., Bement W.J., Wrighton S.A., Sinclair P.R. and Sinclair J.F. (1997b) Role of CYP3A in ethanol-mediated in- creases in acetaminophen hepatotoxicity. Toxicology & Applied Pharmacology 143:315–323.
  • Koymans L., Donné-Op den Kelder G.M., Te Koppele J.M. and Vermeulen N.P.E. (1993) Generalized cytochrome P450–mediated oxidation and oxygenation reactions in aromatic substrates with activated N-H, O-H, C-H, or S-H substituents. Xenobiotica 23:633–648.
  • Koymans L., Van Lenthe J.H., Van de Straat R., Donné-Op den Kelder G.M. and Vermeulen N.P.E. (1989) A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. Chemical Research in Toxicology 2:60–66.
  • Krishna R.G. and Wold F. (1993) Post-translational modifi- cation of proteins. Advances in Enzymology & Re- lated Areas of Molecular Biology 67:265–298.
  • Kulmacz R.J., Palmer G. and Tsai A.L. (1991) Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents. Molecular Phar- macology 40:833–837.
  • Kulmacz R.J., Pendleton R.B. and Lands W.E.M. (1994) Interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase - Interpretation of reaction kinetics. The Journal of Bio- logical Chemistry 269:5527–5536.
  • Kyle M.E., Miccadei S., Nakae D. and Farber J.L. (1987) Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochemical & Biophysical Research Communica- tions 149:889–896.
  • Kyle M.E., Sakaida I., Serroni A. and Farber J.L. (1990) Me- tabolism of acetaminophen by cultured rat hepatocytes. Depletion of protein thiol groups without any loss of viability. Biochemical Pharmacology 40:1211–1218.
  • Landin J.S., Cohen S.D. and Khairallah E.A. (1996) Identi- fication of a 54–kDa mitochondrial acetaminophen- binding protein as aldehyde dehydrogenase. Toxicol- ogy & Applied Pharmacology 141:299–307.
  • Lanfear J., Fleming J., Walker M. and Harrison P. (1993) Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetami- nophen-binding proteins in normal tissues and during carcinogenesis. Carcinogenesis 14:335–340.
  • Larrauri A., Fabra R., Gómez-Lechón M.J., Trullenque R. and Castell J.V. (1987) Toxicity of paracetamol in human hepatocytes. Comparison of the protective effects of sulfhydryl compounds acting as glutathione precursors. Molecular Toxicology 1:301–311.
  • Larsson R., Ross D., Berlin T., Olsson L.I. and Moldéus P. (1985) Prostaglandin synthase catalyzed metabolic activation of p-phenetidine and acetaminophen by microsomes isolated from rabbit and human kidney. Journal of Pharmacology & Experimental Therapeu- tics 235:475–480.
  • Laskin D.L. (1994) Nonparenchymal cells, inflammaroty mediators, and hepatotoxicity, In: Xenobiotics and Inflammation, edited by LBSaDL Laskin (London: Academic Press, Inc.), pp 301–320.
  • Laskin D.L., Gardner C.R., Price V.F. and Jollow D.J. (1995) Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21:1045–1050.
  • Lau S.S., Peters M.M., Kleiner H.E., Canales P.L. and Monks T.J. (1996) Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. Ad- vances in Experimental Medicine & Biology 387:267– 73.
  • Lee C.A., Lillibridge J.H., Nelson S.D. and Slattery J.T. (1996a) Effects of caffeine and theophylline on ac- etaminophen pharmacokinetics: P450 inhibition and activation. Journal of Pharmacology & Experimental Therapeutics 277:287–291.
  • Lee C.A., Thummel K.E., Kalhorn T.F., Nelson S.D. and Slattery J.T. (1991a) Activation of acetaminophen- reactive metabolite formation by methylxanthines and known cytochrome P-450 activators. Drug Metabo- lism & Disposition 19:966–971.
  • Lee C.A., Thummel K.E., Kalhorn T.F., Nelson S.D. and Slattery J.T. (1991b) Inhibition and activation of ac- etaminophen reactive metabolite formation by caf- feine. Roles of cytochromes P-450IA1 and IIIA2. Drug Metabolism & Disposition 19:348–353.
  • Lee S.S.T., Buters J.T.M., Pineau T. and Fernandez-Salguero P. (1996b) Role of CYP2E1 in the hepatotoxicity of acetaminophen. The Journal of Biological Chemistry 271:12063–12067.
  • Leonard T.B., Morgan D.G. and Dent J.G. (1985) Ranitidine- acetaminophen interaction: effects on acetaminophen- induced hepatotoxicity in Fischer 344 rats. Hepatology 5:480–487.
  • Lewis D.F.V., Ioannides C. and Parke D.F. (1987) Structural requirements for substrates of cytochromes P-450 and P-448. Chemico-Biological Interactions 64:39–60.
  • Li Q.-J., Bessems J.G.M., Commandeur J.N.M., Adams B. and Vermeulen N.P.E. (1994a) Mechanism of protec- tion of ebselen against paracetamol-induced toxicity in rat hepatocytes. Biochemical Pharmacology 48:1631–1640.
  • Li Y., Wang E., Patten C.J., Chen L. and Yang C.S. (1994b) Effects of flavonoids on cytochrome P450–dependent acetaminophen metabolism in rats and human liver microsomes. Drug Metabolism & Disposition 22:566– 571.
  • Li Y., Wang E.J., Chen L., Stein A.P., Reuhl K.R. and Yang C.S. (1997) Effects of phenethyl isothiocyanate on acetaminophen metabolism and hepatotoxicity in mice. Toxicology & Applied Pharmacology 144: 306–314.Lim S.P., Andrews F.J. and O’Brien P.E. (1995) Acetami- nophen-induced microvascular injury in the rat liver: Protection with misoprostol. Hepatology 22:1776–1781.
  • Lister C.F. and McLean A.E.M. (1997) Inhibition of DNA synthesis by paracetamol in different tissues of the rat in vivo. Toxicology 116:49–57.
  • Liu J., Liu Y., Madhu C. and Klaassen C.D. (1993a) Protec- tive effects of oleanolic acid on acetaminophen-in- duced hepatotoxicity in mice. Journal of Pharmacol- ogy & Experimental Therapeutics 266:1607–1613.
  • Liu J., Liu Y.P., Bullock P. and Klaassen C.D. (1995a) Suppression of liver cytochrome P450 by alpha-hederin - Relevance to hepatoprotection. Toxicology & Ap- plied Pharmacology 134:124–131.
  • Liu J., Liu Y.P., Parkinson A. and Klaassen C.D. (1995b) Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice. Journal of Pharma- cology & Experimental Therapeutics 275:768–774.
  • Liu P.T., Ioannides C., Shavila J., Symons A.M. and Parke D.V. (1993b) Effects of ether anaesthesia and fasting on various cytochromes P450 of rat liver and kidney. Biochemical Pharmacology 45:871–877.
  • Loew G.H. and Goldblum A. (1985) Metabolic activation and toxicity of acetaminophen and related analogs. A theoretical study. Molecular Pharmacology 27:375– 386.
  • Lubek B.M., Avaria M., Basu P.K. and Wells P.G. (1988a) Pharmacological studies on the in vivo cataracto- genicity of acetaminophen in mice and rabbits. Fun- damental & Applied Toxicology 10:596–606.
  • Lubek B.M., Basu P.K. and Wells P.G. (1988b) Metabolic evidence for the involvement of enzymatic bioacti- vation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/ 2) murine strains. Toxicology & Applied Pharmacol- ogy 94:487–495.
  • Madhu C., Gregus Z. and Klaassen C.D. (1989) Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemi- cals that alter acetaminophen hepatotoxicity. Journal of Pharmacology & Experimental Therapeutics 248:1069–1077.
  • Madhu C. and Klaassen C.D. (1991) Protective effect of pregnenolone-16 alpha-carbonitrile on acetaminophen- induced hepatotoxicity in hamsters. Toxicology & Applied Pharmacology 109:305–313.
  • Madhu C., Maziasz T. and Klaassen C.D. (1992) Effect of pregnenolone-16 alpha-carbonitrile and dexametha- sone on acetaminophen-induced hepatotoxicity in mice. Toxicology & Applied Pharmacology 115:191– 198.
  • Malmberg A.B. and Yaksh T.L. (1982) Hyperalgesia medi- ated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257:1276–1279.
  • Manautou J.E., Hoivik D.J., Tveit A., Hart S.G., Khairallah E.A. and Cohen S.D. (1994) Clofibrate pretreatment diminishes acetaminophen’s selective covalent bind- ing and hepatotoxicity. Toxicology & Applied Phar- macology 129:252–263.
  • Manautou J.E., Khairallah E.A. and Cohen S.D. (1995) Evi- dence for common binding of acetaminophen and bromobenzene to the 58–kDa acetaminophen-binding protein. Journal of Toxicology and Environmental Health 46:263–269.
  • Manautou J.E., Tveit A., Hoivik D.J., Khairallah E.A. and Cohen S.D. (1996) Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentra- tion of acetaminophen-glutathione adducts. Toxicol- ogy & Applied Pharmacology 140:30–38.
  • Manning B.W., Franklin M.R. and Galinsky R.E. (1991) Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetami- nophen disposition in rats. Drug Metabolism & Dis- position 19:498–502.
  • Martin F.L. and McLean A.E.M. (1996) Comparison of protection by fructose against paracetamol injury with protection by glucose and fructose-1,6–diphosphate. Toxicology 108:175–184.
  • Mason R.P. and Fischer V. (1986) Free radicals of acetami- nophen: their subsequent reactions and toxicological significance. Federation Proceedings 45: 2493–2499.Mason R.P. and Fischer V. (1992) Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety 7:45–50.
  • Mattamal M.B., Zenser T.V., Brown W.B., Herman C.A. and Davis B.B. (1979) Mechanism of inhibition of renal prostaglandin production by acetaminophen. Journal of Pharmacology and Experimental Thera- peutics 210:405–409.
  • Matthews A.M., Hinson J.A., Roberts D.W. and Pumford N.R. (1997) Comparison of covalent binding of ac- etaminophen and the regioisomer 3’-hydro- xyacetanilide to mouse liver protein. Toxicology Let- ters 90:77–82.
  • Matthews A.M., Roberts D.W., Hinson J.A. and Pumford N.R. (1996) Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine. Drug Metabolism & Disposition 24:1192– 1196.
  • Mehendale H.M. (1991) Commentary: role of hepatocel- lular regeneration and hepatocellular healing in final outcome of liver injury. A two stage model of toxicity. Biochemical Pharmacology 42:1155– 1162.
  • Mehendale H.M. (1995) Toxicodynamics of low level toxi- cant interactions of biological significance: inhibition of tissue repair. Toxicology 105:251–266.
  • Mehendale H.M., Roth R.A., Gandolfi A.J., Klaunig J.E., Lemasters J.J. and Curtis L.R. (1994a) Novel mecha- nisms in chemically induced hepatotoxicity. FASEB Journal 8:1285–1295.
  • Mehendale H.M., Thakore K.N. and Rao C.V. (1994b) Autoprotection: stimulated tissue repair permits re- covery from injury. Journal of Biochemical Toxicol- ogy 9:131–139.
  • Metodiewa D., Pires de Melo M., Escobar J., Cilento G. and Dunford H. (1992) Horseradish peroxidase-catalyzed aerobic oxidation and peroxidation of indole-3–acetic acid. Archives of Biochemistry and Biophysics 296:27– 33.
  • Meyers L.L., Beierschmitt W.P., Khairallah E.A. and Cohen S.D. (1988) Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicology & Applied Pharmacology 93:378–387.
  • Miller M.G., Beyer J., Hall G.L., deGraffenried L.A. and Adams P.E. (1993) Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant. Toxicology & Applied Pharmacology 122:108–116.
  • Miller M.G. and Jollow D.J. (1984) Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and cova- lent binding in hamsters: Evidence that in vitro cova- lent binding differs from that in vivo. Drug Metabo- lism and Disposition 12:271–279.
  • Miller M.R., Wentz E. and Ong S. (1999) Acetaminophen alters estrogenic responses in vitro: Inhibition of es- trogen-dependent vitellogenin production in trout liver cells. Toxicological Sciences 48:30–37.
  • Miner D.J. and Kissinger P.T. (1979) Evidence for the in- volvement of N-acetyl-p-quinoneimine in acetami- nophen metabolism. Biochemical Pharmacology 28:3285–3290.
  • Miners J.O., Robson R.A. and Birkett D.J. (1986) Paracetamol metabolism in pregnancy. British Journal of Clinical Pharmacology 22:359–362.
  • Mitchell D.B., Acosta D. and Bruckner J.V. (1985) Role of glutathione depletion in the cytotoxicity of acetami- nophen in a primary culture system of rat hepatocytes. Toxicology 37:127–146.
  • Mitchell J.R., Jollow D.J., Potter W.Z., Davis D.C., Gillette J.R. and Brodie B.B. (1973a) Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Journal of Pharmacology & Experimental Therapeutics 187:185–194.
  • Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R. and Brodie B.B. (1973b) Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. Journal of Pharmacology & Experimental Therapeutics 187:211– 217.
  • Mitchell M.C., Hamilton R., Wacker L. and Branch R.A. (1989) Zonal distribution of paracetamol glucuronidation in the isolated perfused rat liver. Xenobiotica 19:389–400.
  • Mizuma T., Hayashi M. and Awazu S. (1985) Factors influ- encing sulfate and glucuronic acid conjugation rates in isolated rat hepatocytes: significance of preincuba- tion time. Biochemical Pharmacology 34:2573–2575.
  • Mohandas J., Duggin G.G., Horvath J.S. and Tiller D.J. (1981) Regional differences in peroxidatic activation of paracetamol (acetaminophen) mediated by cyto- chrome P450 and prostaglandin endoperoxide syn- thetase in rabbit kidney. Research Communications in Chemical Pathology & Pharmacology 34:69–80.
  • Moldéus P. (1978) Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochemical Pharmacology 27:2859–2863.
  • Moldéus P., Andersson B., Rahimtula A. and Berggren M. (1982) Prostaglandin synthetase catalyzed activation of paracetamol. Biochemical Pharmacology 31:1363– 1368.
  • Moldéus P. and Rahimtula A. (1980) Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase. Biochemical & Biophysical Research Communications 96:469–475.
  • Möller-Hartmann W. and Siegers C.-P. (1991) Nephrotoxic- ity of paracetamol in the rat—mechanistic and thera- peutic aspects. Journal of Applied Toxicology 11:141– 146.
  • Moore M., Thor H., Moore G., Nelson S., Moldéus P. and Orrenius S. (1985) The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepato- cytes is associated with thiol depletion and increased cytosolic Ca2+. Journal of Biological Chemistry 260:13035–13040.
  • Morgan E.T., Koop D.R. and Coon M.J. (1983) Comparison of six rabbit liver cytochrome P-450 isozymes in for- mation of a reactive metabolite of acetaminophen. Biochemical & Biophysical Research Communica- tions 112:8–13.
  • Mourelle M., Beales D. and McLean A.E. (1990) Electron transport and protection of liver slices in the late stage of paracetamol injury. Biochemical Pharmacology 40:2023–2028.
  • Mourelle M., Beales D. and McLean A.E. (1991) Prevention of paracetamol-induced liver injury by fructose. Bio- chemical Pharmacology 41:1831–1837.
  • Mrochek J.E., Christie W.H. and Dinsmore S.R. (1974) Acetaminophen metabolism in man, as determined by high-resolution liquid chromatography. Clinical Chem- istry 20:1086–1096.
  • Mugford C.A. and Tarloff J.B. (1995) Contribution of oxida- tion and deacetylation to the bioactivation of acetami- nophen in vitro in liver and kidney from male and female Sprague-Dawley rats. Drug Metabolism & Disposition 23:290–294.
  • Mulder G.J. (1990) Competition between conjugations for the same substrate, In: Conjugation reactions in drug metabolism, edited by GJ Mulder (London: Taylor and Francis), pp 41–49.
  • Mulder G.J., Coughtrie M.W.H. and Burchell B. (1990) Glucuronidation, In: Conjugation reactions in drug metabolism, edited by GJ Mulder (London: Taylor and Francis), pp 51–105.
  • Myers T.G., Dietz E.C., Anderson N.L., Khairallah E.A., Cohen S.D. and Nelson S.D. (1995) A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3’-hydroxyacetanilide. Chemical Re- search in Toxicology 8:403–413.
  • Myers T.G., Thummel K.E., Kalhorn T.F. and Nelson S.D. (1994) Preferred orientations in the binding of 4’- hydroxyacetanilide (acetaminophen) to cytochrome- P450 1A1 and 2B1 isoforms as determined by C-13– NMR and N-15–NMR relaxation studies. Journal of Medicinal Chemistry 37:860–867.
  • Nagasawa H.T., Goon D.J., Muldoon W.P. and Zera R.T. (1984) 2–Substituted thiazolidine-4(R)-carboxylic ac- ids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity. Journal of Medicinal Chemistry 27:591–596.
  • Nastevska C., Gerber E., Horbach M., Röhrdanz E. and Kahl R. (1999) Impairment of TNF-a expression and secre- tion in primary rat liver cell cultures by acetami- nophen treatment. Toxicology 133:85–92.
  • Nazareth W.M., Sethi J.K. and McLean A.E. (1991) Effect of paracetamol on mitochondrial membrane function in rat liver slices. Biochemical Pharmacology 42:931– 936.
  • Nelson S., DC Dahlin ea (1981) Peroxidase-mediated forma- tion of reactive metabolites of acetaminophen. Mo- lecular Pharmacology 20:195–199.
  • Nelson S.D. (1995) Mechanisms of the formation and dispo- sition of reactive metabolites that can cause acute liver injury. Drug Metabolism Reviews 27:147–177.
  • Nelson S.D., Forte A.J. and McMurtry R.J. (1978) Decreased toxicity of the N-methyl analogs of acetaminophen and phenacetin. Research Communications in Chemi- cal Pathology & Pharmacology 22:61–71.
  • Nelson S.D., Tirmenstein M.A., Rashed M.S. and Myers T.G. (1990) Acetaminophen and protein thiol modifi- cation. Advances in Experimental Medicine and Biol- ogy (Biological Reactive Intermediates IV - Molecu- lar and cellular effects and their impact on human health) 283:579–588.
  • Nelson S.D., Tirmenstein M.A., Rashed M.S. and Myers T.G. (1991) Acetaminophen and protein thiol modifi- cation. Advances in Experimental Medicine & Biol- ogy 283:579–588.
  • Neuvonen P.J., Tokola O., Toivonen M.L. and Simell O. (1985) Methionine in paracetamol tablets, a tool to reduce paracetamol toxicity. International Journal of Clinical Pharmacology, Therapy, & Toxicology 23:497–500.
  • Newton J.F., Bailie M.B. and Hook J.B. (1983) Acetami- nophen nephrotoxicity in the rat. Renal metabolic activation in vitro. Toxicology & Applied Pharmacol- ogy 70:433–444.
  • Newton J.F., Hoefle D., Gemborys M.W., Mudge G.H. and Hook J.B. (1986) Metabolism and excretion of a glu- tathione conjugate of acetaminophen in the isolated perfused rat kidney. Journal of Pharmacology & Ex- perimental Therapeutics 237:519–524.
  • Newton J.F., Kuo C.H., DeShone G.M., Hoefle D., Bernstein J. and Hook J.B. (1985a) The role of p-aminophenol in acetaminophen-induced nephrotoxicity: effect of bis(p-nitrophenyl) phosphate on acetaminophen and p-aminophenol nephrotoxicity and metabolism in Fischer 344 rats. Toxicology & Applied Pharmacol- ogy 81:416–430.
  • Newton J.F., Pasino D.A. and Hook J.B. (1985b) Acetami- nophen nephrotoxicity in the rat: quantitation of renal metabolic activation in vivo. Toxicology & Applied Pharmacology 78:39–46.
  • Nicholls-Grzemski F.A., Calder I.C. and Priestly B.G. (1992) Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. Biochemical Pharmacology 43:1395–1396.
  • Nickl J., Müller E., Narr B. and Engelhardt G. (1988) 3,5– Dihalogen-acylanilide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung. Patent DE 37 01 517 A1, 4th August 1988, pp 1–20, Deutsches Patentamt, Germany. Dr. Karl Thomae Gmbh.
  • Nicotera P., Hinds T.R., Nelson S.D. and Vincenzi F.F. (1990) Differential effects of arylating and oxidizing analogs of N-acetyl-p-benzoquinoneimine on red blood cell membrane proteins. Archives of Biochemistry & Biophysics 283:200–205.
  • Nordmann R., Ribiere C. and Rouach H. (1992) Implication of free radical mechanisms in ethanol-induced cellu- lar injury. Free Radical Biology and Medicine 12:219– 240.
  • Novak M., Bonham G.A., Mulero J.J., Pelecanou M., Zemis J.N., Buccigross J.M. and Wilson T.C. (1989) Hy- drolysis of N-acetyl-p-benzoquinone imines: pH de- pendence of the partitioning of a tetrahedral interme- diate. Journal of the American Chemical Society 111:4447–4456.
  • Novak M., Pelecanou M. and Pollack L. (1986) Hydrolysis of the model carcinogen N-(pivaloyloxy)-4– methoxyacetanilide: Involvement of N-acetyl-p-ben- zoquinone imine. Journal of the American Chemical Society 108:112–120.
  • O’Brien P.J., Khan S. and Jatoe S.D. (1990) Formation of biological reactive intermediates by peroxidases: ha- lide mediated acetaminophen oxidation and cytotox- icity, In: Advances in Experimental Medicine and Biology (Biological Reactive Intermediates IV - Mo- lecular and cellular effects and their impact on human health), edited by CM Witmer, RR Snyder, DJ Jollow, GF Kalf, JJ Kocsis and IG Sipes (New York: Plenum Press), pp 51–64.
  • Pang K.S. (1990) Kinetics of conjugation reactions in elimi- nating organs, In: Conjugation reactions in drug me- tabolism, edited by GJ Mulder (London: Taylor and Francis), pp 5–39.
  • Park B.K. and Kitteringham N.R. (1994) Effects of fluorine substitution on drug metabolism: Pharmacological and toxicological implications. Drug Metabolism Reviews 26:605–643.
  • Pascoe G.A., Calleman C.J. and Baillie T.A. (1988) Identi- fication of S-(2,5–dihydroxyphenyl)-cysteine and S- (2,5–dihydroxyphenyl)-N-acetyl-cysteine as urinary metabolites of acetaminophen in the mouse. Evidence for p-benzoquinone as a reactive intermediate in ac- etaminophen metabolism. Chemico-Biological Inter- actions 68:85–98.
  • Patierno S.R., Lehman N.L., Henderson B.E. and Landolph J.R. (1989) Study of the ability of phenacetin, ac- etaminophen, and aspirin to induce cytotoxicity, mu- tation, and morphological transformation in C3H/10T1/ 2 clone 8 mouse embryo cells. Cancer Research 49:1038–1044.
  • Patten C.J., Thomas P.E., Guy R.L., Lee M., Gonzalez F.J., Guengerich F.P. and Yang C.S. (1993) Cytochrome P450 enzymes involved in acetaminophen activation by rat liver microsomes and their kinetics. Chemical Research in Toxicology 6:511–518.
  • Peters M.M.C.G., Lau S.S., Dulik D., Murphy D., Van Ommen B., Van Bladeren P.J. and Monks T.J. (1996) Metabolism of tert-butylhydroquinone to S-Substi- tuted conjugates in the male fischer 344 rat. Chemical Research in Toxicology 9:133–139.
  • Pfeiffer E. and Metzler M. (1996) Interaction of p-benzo- quinone and p-biphenoquinone with microtubule pro- teins in vitro. Chemico-Biological Interactions 102:37– 53.
  • Pieper H., Krüger G., Keck J. and Engelhardt G. (1987) Acylanilide enthaltende Arzneimittel, neue Acylanilide, deren Verwendung und Verfahren zu ihrer Herstellung. Patent DE 35 34 765 A1, 2nd April 1987, pp 1–28, Germany. Dr. Karl Thomae Gmbh.
  • Pirmohamed M., Madden S. and Park B.K. (1996) Idiosyn- cratic drug reactions. Metabolic bioactivation as a pathogenic mechanism. Clinical Pharmacokinetics 31:215–230.
  • Ploemen J.H.T.M., Wormhoudt L.W., Haenen G.R.M.M., Oudshoorn M.J., Commandeur J.N.M., Vermeulen N.P.E., De Waziers I., Beaune P.H., Watabe T. and Van Bladeren P.J. (1997) The use of in vitro meta- bolic parameters to explore the risk assessment of hazardous compounds: The case of ethylene dibromide. Toxicology and Applied Pharmacology 143:56–69.
  • Ponsoda X., Jover R., Gomez-Lechon M.J., Fabra R., Trullenque R. and Castell J.V. (1991) Intracellular glutathione in human hepatocytes incubated with S- adenosyl-L-methionine and GSH-depleting drugs. Toxicology 70:293–302.
  • Porubek D.J., Rundgren M., Harvison P.J., Nelson S.D. and Moldéus P. (1987) Investigation of mechanisms of acetaminophen toxicity in isolated rat hepatocytes with the acetaminophen analogues 3,5–dimethylacetami- nophen and 2,6–dimethylacetami-nophen. Molecular Pharmacology 31:647–653.
  • Potter D.W. and Hinson J.A. (1987) The 1– and 2–electron oxidation of acetaminophen catalyzed by prostaglan- din H synthase. Journal of Biological Chemistry 262:974–980.
  • Potter D.W. and Hinson J.A. (1989) Acetaminophen peroxidation reactions. Drug Metabolism Reviews 20:341–358.
  • Potter D.W., Miller D.W. and Hinson J.A. (1986) Horserad- ish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Molecular Pharmacology 29:155–162.
  • Potter W.Z., Davis D.C., Mitchell J.R., Jollow D.J., Gillette J.R. and Brodie B.B. (1973) Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450–mediated covalent binding in vitro. Journal of Pharmacological & Experimental Therapeutics 187:203–210.
  • Potter W.Z., Thorgeirsson S.S., Jollow D.J. and Mitchell J.R. (1974) Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology 12:129–143.
  • Prescott L.F. (1980) Kinetics and metabolism of paracetamol and phenacetin. British Journal of Clinical Pharma- cology 10: 291S-298S.
  • Prescott L.F. (1983) Paracetamol overdosage. Pharmaco- logical considerations and clinical management. Drugs 25:290–314.
  • Price V.F. and Jollow D.J. (1982) Increased resistance of diabetic rats to acetaminophen-induced hepatotoxic- ity. Journal of Pharmacology & Experimental Thera- peutics 220:504–513.
  • Price V.F. and Jollow D.J. (1986) Strain differences in sus- ceptibility of normal and diabetic rats to acetami- nophen hepatotoxicity. Biochemical Pharmacology 35:687–695.
  • Price V.F. and Jollow D.J. (1988) Mechanism of decreased acetaminophen glucuronidation in the fasted rat. Bio- chemical Pharmacology 37:1067–1075.
  • Price V.F. and Jollow D.J. (1989) Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicology & Applied Pharma- cology 101:356–369.
  • Prox A., Schmid J., Nickl J. and Engelhardt G. (1987) In vivo screening of glutathione related detoxification prod- ucts in the early state of drug development. Zeitschrift für Naturforschung 42c:465–475.
  • Pumford N.R. and Halmes N.C. (1997) Protein targets of xenobiotic reactive intermediates. Annual Review Pharmacology Toxicology 37:91–117.
  • Pumford N.R., Halmes N.C., Martin B.M., Cook R.J., Wagner C. and Hinson J.A. (1997) Covalent binding of ac- etaminophen to N-10–formyltetrahydrofolate dehy- drogenase in mice. Journal of Pharmacology & Ex- perimental Therapeutics 280:501–505.
  • Pumford N.R., Hinson J.A., Benson R.W. and Roberts D.W. (1990a) Immunoblot analysis of protein containing 3– (cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicology & Applied Pharmacology 104:521– 532.
  • Pumford N.R., Hinson J.A., Potter D.W., Rowland K.L., Benson R.W. and Roberts D.W. (1989) Immunochemi- cal quantitation of 3–(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen- treated mice. Journal of Pharmacology & Experimen- tal Therapeutics 248:190–196.
  • Pumford N.R., Martin B.M. and Hinson J.A. (1992) A me- tabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochemical & Bio- physical Research Communications 182:1348–1355.
  • Pumford N.R., Roberts D.W., Benson R.W. and Hinson J.A. (1990b) Immunochemical quantitation of 3–(cystein- S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetami- nophen. Biochemical Pharmacology 40:573–579.
  • Qiu Y., Benet L.Z. and Burlingame A.L. (1998) Identi- fication of protein targets of reactive metabolites of acetaminophen in vivo in mice using two-di- mensional gel electrophoresis and mass spectrom- etry. The Journal of Biological Chemistry 273:17940–17953.
  • Qu W., Savier E. and Thurman R.G. (1992) Stimulation of oxygenation and conjugation after liver transplanta- tion in the rat: involvement of Kupffer cells. Molecu- lar Pharmacology 41:1149–1154.
  • Ramakrishna Rao D.N., Fischer V. and Mason R.P. (1990) Glutathione and ascorbate reduction of the acetami- nophen radical formed by peroxidase. Detection of the glutathione disulfide radical anion and the ascorbyl radical. Journal of Biological Chemistry 265:844– 847.
  • Ramsay R.R., Rashed M.S. and Nelson S.D. (1989) In vitro effects of acetaminophen metabolites and analogs on the respiration of mouse liver mitochondria. Archives of Biochemistry and Biophysics 273:449–457.
  • Rannug U., Holme J.A., Hongslo J.K. and Sram R. (1995) International Commission for Protection against En- vironmental Mutagens and Carcinogens. An evalua- tion of the genetic toxicity of paracetamol. Mutation Research 327:179–200.
  • Rashba-Step J., Turro N.J. and Cederbaum A.I. (1993) In- creased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Archives of Biochem- istry & Biophysics 300:401–408.
  • Rashed M.S., Myers T.G. and Nelson S.D. (1990) Hepatic protein arylation, glutathione depletion, and metabo- lite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3’-hydroxyacetanilide, in the mouse. Drug Metabolism & Disposition 18:765–770.
  • Rashed M.S. and Nelson S.D. (1989a) Characterization of glutathione conjugates of reactive metabolites of 3’- hydroxyacetanilide, a nonhepatotoxic positional iso- mer of acetaminophen. Chemical Research in Toxi- cology 2:41–45.
  • Rashed M.S. and Nelson S.D. (1989b) Use of thermospray liquid chromatography-mass spectrometry for charac- terization of reactive metabolites of 3’-hydro- xyacetanilide, a non-hepatotoxic regioisomer of acetaminophen. Journal of Chromatography 474:209– 222.
  • Raucy J.L., Lasker J.M., Lieber C.S. and Black M. (1989) Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Archives of Biochemistry & Biophysics 271:270–283.
  • Ray S.D., Kamendulis L.M., Gurule M.W., Yorkin R.D. and Corcoran G.B. (1993) Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by ac- etaminophen. FASEB Journal 7:453–463.
  • Ray S.D., Mumaw V.R., Raje R.R. and Fariss M.W. (1996) Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. Journal of Pharmacology & Experi- mental Therapeutics 279:1470–1483.
  • Ray S.D., Sorge C.L., Raucy J.L. and Corcoran G.B. (1990) Early loss of large genomic DNA in vivo with accu- mulation of Ca2+ in the nucleus during acetaminophen- induced liver injury. Toxicology & Applied Pharma- cology 106:346–351.
  • Ray S.D., Sorge C.L., Tavacoli A., Raucy J.L. and Corcoran G.B. (1991) Extensive alteration of genomic DNA and rise in nuclear Ca2+ in vivo early after hepatotoxic acetaminophen overdose in mice. Advances in Experimental Medicine & Biology 283:699–705.
  • Remirez D., Commandeur J.N.M., Groot E. and Vermeulen N.P.E. (1995) Mechanism of protection of lobenzarit against paracetamol-induced toxicity in rat hepato- cytes. European Journal of Pharmacology - Environ- mental Toxicology and Pharmacology Section 293:301–308.
  • Richard A.M., Hongslo J.K., Boone P.F. and Holme J.A. (1991) Structure-activity study of paracetamol ana- logues: inhibition of replicative DNA synthesis in V79 Chinese hamster cells. Chemical Research in Toxicology 4:151–156.
  • Richie J.P., Jr., Lang C.A. and Chen T.S. (1992) Acetami- nophen-induced depletion of glutathione and cysteine in the aging mouse kidney. Biochemical Pharmacol- ogy 44:129–135.
  • Roberts D.W., Bucci T.J., Benson R.W., Warbritton A.R., McRae T.A., Pumford N.R. and Hinson J.A. (1991) Immunohistochemical localization and quantification of the 3–(cystein-S-yl)acetaminophen-protein adduct in acetaminophen hepatotoxicity. American Journal of Pathology 138:359–371.
  • Roberts D.W., Pumford N.R., Potter D.W., Benson R.W. and Hinson J.A. (1987a) A sensitive immunochemi- cal assay for acetaminophen-protein adducts. Journal of Pharmacology & Experimental Therapeutics 241:527–533.
  • Roberts J.C., Charyulu R.L., Zera R.T. and Nagasawa H.T. (1992) Protection against acetaminophen hepatotox- icity by ribose-cysteine (RibCys). Pharmacology & Toxicology 70:281–285.
  • Roberts J.C., Nagasawa H.T., Zera R.T., Fricke R.F. and Goon D.J. (1987b) Prodrugs of L-cysteine as protec- tive agents against acetaminophen-induced hepato- toxicity. 2-(Polyhydroxyalkyl)- and 2–(polyacet- oxyalkyl)thiazolidine-4(R)-carboxylic acids. Journal of Medicinal Chemistry 30:1891–1896.
  • Roberts J.C., Phaneuf H.L., Szakacs J.G., Zera R.T., LambJ.G. and Franklin M.R. (1998) Differential chemo- protection against acetaminophen-induced hepatotox- icity by latentiated L-cysteines. Chemical Research in Toxicology 11:1274–1282.
  • Roberts S.A. and Jollow D.J. (1978) Acetaminophen struc- ture-toxicity relationships: why is 3–hydro- xyacetanilide not hepatotoxic. Pharmacologist 20:259. Roberts S.A. and Jollow D.J. (1979) Acetaminophen struc- ture-toxicity studies: lack of liver necrosis after 2–hydroxyacetanilide. Pharmacologist 21:220.
  • Roberts S.A. and Jollow D.J. (1980) Acetaminophen struc- ture-toxicity studies: in vivo covalent binding of a non-hepatotoxic analog, 2–hydroxyacetanilide. Fed- eration Proceedings 39:748.
  • Roberts S.A., Price V.F. and Jollow D.J. (1990) Acetami- nophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3–hydro- xyacetanilide. Toxicology & Applied Pharmacology 105:195–208.
  • Rogers L.K., Moorthy B. and Smith C.V. (1997) Acetami- nophen binds to mouse hepatic and renal DNA at human therapeutic doses. Chemical Research in Toxi- cology 10:470–476.
  • Rogers S.A., Gale K.C., Newton J.F., Dent J.G. and Leonard T.B. (1988) Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine poten- tiation of acetaminophen-induced hepatotoxicity. Jour- nal of Pharmacology & Experimental Therapeutics 245:887–894.
  • Ross D., Larsson R., Andersson B., Nilsson U., Lindquist T., Lindeke B. and Moldéus P. (1985) The oxidation of p- phenetidine by horseradish peroxidase and prostag- landin synthase and the fate of glutathione during such oxidations. Biochemical Pharmacology 34:343– 351.
  • Rossi L., McGirr L.G., Silva J. and O’Brien P.J. (1988) The metabolism of N-acetyl-3,5–dimethyl-p-benzoquinone imine in isolated heaptocytes involves N-deacetylation. Molecular Pharmacology 34:674–681.
  • Rundgren M., Porubek D.J., Harvison P.J., Cotgreave I.A., Moldéus P. and Nelson S.D. (1988) Comparative cy- totoxic effects of N-acetyl-p-benzoquinone imine and two dimethylated analogues. Molecular Pharmacol- ogy 34:566–572.
  • Salminen W.F.J., Roberts S.M., Pumford N.R. and Hinson J.A. (1998) Immunochemical comparison of 3’- hydroxyacetanilide and acetaminophen binding in mouse liver. Drug Metabolism and Disposition 26:267–271.
  • Salminen W.F.J., Voellmy R. and Roberts S.M. (1997) Pro- tection against hepatotoxicity by a single dose of amphetamine: The potential role of heat shock protein induction. Toxicology and Applied Pharmacology 147:247–258.
  • Sandler D.P., Smith J.C., Weinberg C.R., Buckalew V.M., Jr., Dennis V.W., Blythe W.B. and Burgess W.P. (1989) Analgesic use and chronic renal disease. New England Journal of Medicine 320:1238–1243.
  • Sato C. and Izumi N. (1989) Mechanism of increased hepa- totoxicity of acetaminophen by the simultaneous ad- ministration of caffeine in the rat. Journal of Pharma- cology & Experimental Therapeutics 248: 1243–1247.Schnell R.C., Park K.S., Davies M.H., Merrick B.A. and Weir S.W. (1988) Protective effects of selenium on acetaminophen-induced hepatotoxicity in the rat. Toxicology and Applied Pharmacology 95:1–11.
  • Schnellmann R.G. (1998) Analgesic nephropathy in rodents. Journal of Toxicology and Environmental Health Part B: Critical Reviews 1:81–90.
  • Shen W., Kamendulis L.M., Ray S.D. and Corcoran G.B. (1992) Acetaminophen-induced cytotoxicity in cul- tured mouse hepatocytes: effects of Ca(2+)-endonu- clease, DNA repair, and glutathione depletion inhibi- tors on DNA fragmentation and cell death. Toxicology & Applied Pharmacology 112:32–40.
  • Shimada T., Yamazaki H., Mimura M., Inui Y. and Guengerich F.P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology & Ex- perimental Therapeutics 270:414–423.
  • Shrivastava R., John G., Chevalier A., Beaughard M., Rispat G., Slaoui M. and Massingham R. (1994) Paracetamol potentiates isaxonine toxicity in vitro. Toxicology Letters 73:167–173.
  • Sies H. (1986) Biochemistry of oxidative stress. Angew Chem Int Ed Engl 25:1058–1071.
  • Skoglund L.A., Ingebrigtsen K., Nafstad I. and Aalen O. (1986) Efficacy of paracetamol-esterified methionine versus cysteine or methionine on paracetamol-induced hepatic GSH depletion and plasma ALAT level in mice. Biochemical Pharmacology 35:3071–3075.
  • Skoglund L.A., Ingebrigtsen K., Nafstad I. and Aalen O. (1988) In vivo studies on toxic effects of concurrent administration of paracetamol and its N-acetyl-DL- methionine ester (SUR 2647 combination). General Pharmacology 19:213–217.
  • Skoglund L.A., Ingebrigtsen K., Nafstad I. and Jansen J.H. (1987) Time development of distribution and toxicity following single toxic APAP doses in male BOM:NMRI mice. Journal of Applied Toxicology 7:1– 6.
  • Skorpen F., Alm B., C. S., Aas P.A. and Krokan H.E. (1998) Paracetamol increases sensitivity to ultraviolet (UV) irradiation, delays repair of the UNG-gene and recov- ery of RNA synthesis in HaCaT cells. Chemico-Bio- logical Interactions 110:123–136.
  • Slattery J.T., Wilson J.M., Kalhorn T.F. and Nelson S.D. (1987) Dose-dependent pharmacokinetics of acetami- nophen: evidence of glutathione depletion in humans. Clinical Pharmacology & Therapeutics 41:413–418.
  • Smith C.V., Hughes H. and Mitchell J.R. (1984) Free radi- cals in vivo. Covalent binding to lipids. Molecular Pharmacology 26:112–116.
  • Smith C.V. and Mitchell J.R. (1985) Acetaminophen hepa- totoxicity in vivo is not accompanied by oxidant stress. Biochemical & Biophysical Research Communica- tions 133:329–336.
  • Smith G.D. and Ciszak E. (1994) The structure of a complex of hexameric insulin and 4’-hydroxyacetanilide. Pro- ceedings of the National Academy of Sciences of the United States of America 91:8851–8855.
  • Smith J.A., Hine I.D., Beck P. and Routledge P.A. (1986) Paracetamol toxicity: is enzyme induction important? Human Toxicology 5:383–385.
  • Snawder J.E., Benson R.W., Leakey J.E. and Roberts D.W. (1993) The effect of propylene glycol on the P450– dependent metabolism of acetaminophen and other chemicals in subcellular fractions of mouse liver. Life Sciences 52:183–189.
  • Snawder J.E., Roe A.L., Benson R.W. and Roberts D.W. (1994) Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity [published erratum appears in Biochem Biophys Res Commun 1995 Jan 5;206(1):437]. Biochemical & Biophysical Research Communications 203:532–539.
  • Soni M.G. and Mehendale H.M. (1998) Role of tissue repair in toxicological interactions among hepatotoxic organics. Environmental Health Perspectives 106, Suppl. 6:1307–1337.
  • Speck R.F., Schranz C. and Lauterburg B.H. (1993) Pred- nisolone stimulates hepatic glutathione synthesis in mice. Protection by prednisolone against acetami- nophen hepatotoxicity in vivo. Journal of Hepatology 18:62–67.
  • Spielberg S.P. and Gordon G.B. (1981) Glutathione syn- thetase-deficient lymphocytes and acetaminophen tox- icity. Clinical Pharmacology & Therapeutics 29:51– 55.
  • Spooner J. (1995) Paracetamol and self poisoning. British Medical Journal 310:1072.
  • Streeter A.J., Bjorge S.M., Axworthy D.B., Nelson S.D. and Baillie T.A. (1984a) The microsomal metabolism and site of covalent binding to protein of 3’- hydroxyacetanilide, a nonhepatotoxic positional iso- mer of acetaminophen. Drug Metabolism & Disposi- tion 12:565–576.
  • Streeter A.J., Dahlin D.C., Nelson S.D. and Baillie T.A. (1984b) The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. Chemico-Biological Interactions 48:349–366.
  • Stryer L. (1981) Biochemistry (San Francisco: W.H. Free- man and Company).
  • Subrahmanyam V.V., McGirr L.G. and O’Brien P.J. (1987) Glutathione oxidation during peroxidase catalysed drug metabolism. Chemico-Biological Interactions 61:45– 59.
  • Svensson B.E. (1989) Involvement of cysteine, serotonin and their analogues in peroxidase-oxidase reactions. Chemico-Biological Interactions 70:305–321.
  • Thelen M. and Wendel A. (1983) Drug-induced lipid peroxidation in mice—V. Ethane production and glu- tathione release in the isolated liver upon perfusion with acetaminophen. Biochemical Pharmacology 32:1701–1706.
  • Thomas S.H. (1993) Paracetamol (acetaminophen) poison- ing. Pharmacology & Therapeutics 60:91–120.
  • Thomsen M.S., Loft S., Roberts D.W. and Poulsen H.E. (1995) Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepato- toxicity in mice without cytochrome P4501A2 inhibi- tion. Pharmacology & Toxicology 76:395–399.
  • Thummel K.E., Lee C.A., Kunze K.L., Nelson S.D. and Slattery J.T. (1993) Oxidation of acetaminophen to N- acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochemical Pharmacology 45:1563–1569.
  • Thummel K.E., Slattery J.T., Nelson S.D., Lee C.A. and Pearson P.G. (1989) Effect of ethanol on hepatotoxic- ity of acetaminophen in mice and on reactive metabo- lite formation by mouse and human liver microsomes. Toxicology & Applied Pharmacology 100:391–397.
  • Tirmenstein M.A. and Nelson S.D. (1989) Subcellular bind- ing and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3’-hydroxyacetanilide, in mouse liver. The Journal of Biological Chemistry 264:9814–9819.
  • Tirmenstein M.A. and Nelson S.D. (1990) Acetaminophen- induced oxidation of protein thiols: Contribution of impaired thiol-metabolizing enzymes and the break- down of adenine nucleotides. The Journal of Biologi- cal Chemistry 265:3059–3065.
  • Tirmenstein M.A. and Nelson S.D. (1991) Hepatotoxicity after 3’-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice. Chemical Research in Toxicology 4:214–217.
  • To E.C. and Wells P.G. (1985) Repetitive microvolumetric sampling and analysis of acetaminophen and its toxi- cologically relevant metabolites in murine plasma and urine using high performance liquid chromatography. Journal of Analytical Toxicology 9:217–221.
  • Tone Y., Kawamata K., Murakami T., Higashi Y. and Yata N. (1990) Dose-dependent pharmacokinetics and first- pass metabolism of acetaminophen in rats. Journal of Pharmacobio-Dynamics 13:327–335.
  • Tonge R.P., Kelly E.J., Bruschi S.A., Kalhorn T., Eaton D.L., Nebert D.W. and Nelson S.D. (1998) Role of CYP1A2 in the hepatotoxicity of acetaminophen: In- vestigations using Cyp1a2 null mice. Toxicology and Applied Pharmacology 153:102–108.
  • Topinka J., Sram R.J., Sirinjan G., Kocisova J., Binkova B. and Fojtikova I. (1989) Mutagenicity studies on paracetamol in human volunteers. II. Unscheduled DNA synthesis and micronucleus test. Mutation Re- search 227:147–152.
  • Tosh D., Borthwick E.B., Sharp S., Burchell A., Burchell B. and Coughtrie M.W.H. (1996) Heterogeneous expres- sion of sulfotransferases in periportal and perivenous hepatocytes prepared from male and female rat liver. Biochemical Pharmacology 51:369–374.
  • Toxopeus C., van Holsteijn I., de Winther M.P., van den Dobbelsteen D., Horbach G.J., Blaauboer B.J. and Noordhoek J. (1994) Role of thiol homeostasis and adenine nucleotide metabolism in the protective ef- fects of fructose in quinone-induced cytotoxicity in rat hepatocytes. Biochemical Pharmacology 48:1682– 1692.
  • Trumper L., Monasterolo L.A. and Elias M.M. (1996) Neph- rotoxicity of acetaminophen in male Wistar rats - role of hepatically derived metabolites. Journal of Phar- macology & Experimental Therapeutics 279:548–554.
  • Tsokos-Kuhn J.O., Hughes H., Smith C.V. and Mitchell J.R. (1988) Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. Biochemical Pharmacology 37:2125–2131.
  • Tukel S.S. (1995) Effects of acetaminophen on methemoglo- bin, superoxide dismutase and Na(+)-K+ ATPase ac- tivities of human erythrocytes. Biochemistry & Mo- lecular Biology International 35:719–724.
  • Ueng T.H., Ueng Y.F., Chen T.L., Park S.S., Iwasaki M. and Guengerich F.P. (1993) Induction of cytochrome P450–dependent monooxygenases in hamster tissues by fasting. Toxicology & Applied Pharmacology 119:66–73.
  • Uhlig S. and Wendel A. (1990) Glutathione enhancement in various mouse organs and protection by glutathione isopropyl ester against liver injury. Biochemical Phar- macology 39:1877–1881.
  • Van de Straat R., Bijloo G.J. and Vermeulen N.P.E. (1988a) Paracetamol, 3–monoalkyl- and 3,5–dialkyl-substi- tuted derivatives. Antioxidant activity and relation- ship between lipid peroxidation and cytotoxicity. Bio- chemical Pharmacology 37:3473–3476.
  • Van de Straat R., De Vries J., De Boer H.J.R., Vromans R.M. and Vermeulen N.P.E. (1987a) Relationship between paracetamol binding to and its oxidation by two cytochrome P-450 isozymes - a proton nuclear magnetic resonance and spectrophotometric study. Xenobiotica 17:1–9.
  • Van de Straat R., De Vries J., Debets A.J.J. and Vermeulen N.P.E. (1987b) The mechanism of prevention of paracetamol-induced hepatotoxicity by 3,5–dialkyl sub- stitution. The roles of glutathione depletion and oxida- tive stress. Biochemical Pharmacology 36:2065–2070.
  • Van de Straat R., De Vries J., Groot E.J., Zijl R. and Vermeulen N.P.E. (1987c) Paracetamol, 3–monoalkyl- and 3,5–dialkyl derivatives: comparison of their hepa- totoxicity in mice. Toxicology & Applied Pharmacol- ogy 89:183–189.
  • Van de Straat R., De Vries J., Kulkens T., Debets A.J. and Vermeulen N.P.E. (1986) Paracetamol, 3–monoalkyl- and 3,5–dialkyl derivatives. Comparison of their mi- crosomal cytochrome P-450 dependent oxidation and toxicity in freshly isolated hepatocytes. Biochemical Pharmacology 35:3693–3699.
  • Van de Straat R., De Vries J. and Vermeulen N.P.E. (1987d) Role of hepatic microsomal and purified cytochrome P-450 in one-electron reduction of two quinone imi- nes and concomitant reduction of molecular oxygen. Biochemical Pharmacology 36:613–619.
  • Van de Straat R., Vromans R.M., Bosman P., De Vries J. and Vermeulen N.P.E. (1988b) Cytochrome P-450–medi- ated oxidation of substrates by electron-transfer; role of oxygen radicals and of 1– and 2–electron oxidation of paracetamol. Chemico-Biological Interactions 64:267–280.
  • Vendemiale G., Grattagliano I., Altomare E., Turturro N. and Guerrieri F. (1996) Effect Of Acetaminophen Administration On Hepatic Glutathione Compartmentation and Mitochondrial Energy Metabo- lism In the Rat. Biochemical Pharmacology 52:1147– 1154.
  • Vermeulen N.P.E., Baldew G.S., Los G., McVie J.G. and De Goeij J.J. (1993) Reduction of cisplatin nephrotoxic- ity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds. Drug Metabolism & Disposition 21:30–36.
  • Vermeulen N.P.E., Bessems J.G.M. and Van de Straat R. (1992) Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metabolism Reviews 24:367–407.
  • Vigroux A., Bergon M. and Zedde C. (1995) Cyclization- activated prodrugs: N-(substituted 2–hydroxyphenyl and 2–hydroxypropyl)carbamates based on ring- opened derivatives of active benzoxazolones and oxazolidinones as mutual prodrugs of acetaminophen. Journal of Medicinal Chemistry 38:3983–3994.
  • Wang E.J., Li Y., Lin M., Chen L., Stein A.P., Reuhl K.R. and Yang C.S. (1996) Protective effects of garlic and related organosulfur compounds on acetaminophen- induced hepatotoxicity in mice. Toxicology & Applied Pharmacology 136:146–154.
  • Warrander A., Allen J.M. and Andrews R.S. (1985) Incorpo- ration of radiolabelled amino acids into the sulfur- containing metabolites of paracetamol by the hamster. Xenobiotica 15:891–897.
  • Weis M., Kass G.E.N., Orrenius S. and Moldéus P. (1992a) N-Acetyl-p-benzoquinone imine induces Ca2+ release from mitochondria by stimulating pyridine nucleotide hydrolysis. The Journal of Biological Chemistry 267:804–809.
  • Weis M., Morgenstern R., Cotgreave I.A., Nelson S.D. and Moldéus P. (1992b) N-acetyl-p-benzoquinone imine- induced protein thiol modification in isolated rat hepa- tocytes. Biochemical Pharmacology 43:1493–1505.
  • Weis M., Rundgren M., Nelson S. and Moldeus P. (1996) Peroxidase-catalyzed oxidation of 3,5–dimethyl ac- etaminophen causes cell death by selective protein thiol modification in isolated rat hepatocytes. Chemico- Biological Interactions 100:255–265.
  • Wells P.G., Wilson B., Winn L.M. and Lubek B.M. (1995) In vivo murine studies on the biochemical mechanism of acetaminophen cataractogenicity. Canadian Jour- nal of Physiology & Pharmacology 73:1123–1129.
  • Welty S.E., Smith C.V., Benzick A.E., Montgomery C.A. and Hansen T.N. (1993) Investigation of possible mechanisms of hepatic swelling and necrosis caused by acetaminophen in mice. Biochemical Pharmacol- ogy 45:449–458.
  • Wendel A. and Cikryt P. (1981) Binding of paracetamol metabolites to mouse liver glutathione S-transferases. Research Communications in Chemical Pathology & Pharmacology 33:463–473.
  • Wendel A., Feuerstein S. and Konz K.-H. (1979) Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. Biochemical Pharmacology 28:2051–2055.
  • Wendel A. and Hallbach J. (1986) Quantitative assessment of the binding of acetaminophen metabolites to mouse liver microsomal phospholipid. Biochemical Pharma- cology 35:385–389.
  • Wendel A., Jaeschke H. and Gloger M. (1982) Drug-induced lipid peroxidation in mice—II. Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione. Biochemical Phar- macology 31:3601–3605.
  • Whitehouse L.W., Paul C.J. and Thomas B.H. (1976) Effect of acetylsalicylic acid on a toxic dose of acetami- nophen in the mouse. Toxicology & Applied Pharma- cology 38:571–582.
  • Wiger R., Finstad H.S., Hongslo J.K., Haug K. and Holme J.A. (1997) Paracetamol inhibits cell cycling and in- duces apoptosis in HL-60 cells. Pharmacology and Toxicology 81:285–293.
  • Williamson J.M., Boettcher B. and Meister A. (1982) Intra- cellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proceed- ings of the National Academy of Sciences of the United States of America 79:6246–6249.
  • Willson R.A., Hart J. and Hall T. (1991) The concentration and temporal relationships of acetaminophen-induced changes in intracellular and extracellular total glu- tathione in freshly isolated hepatocytes from untreated and 3-methylcholanthrene pretreated Sprague-Dawley and Fischer rats. Pharmacology & Toxicology 69:205– 212.
  • Wong L.T., Solomonraj G. and Thomas B.H. (1976) High- pressure liquid chromatographic determination of ac- etaminophen in biological fluids. Journal of Pharma- ceutical Sciences 65:1064–1066.
  • Woo P.C., Kaan S.K. and Cho C.H. (1995) Evidence for potential application of zinc as an antidote to acetami- nophen-induced hepatotoxicity. European Journal of Pharmacology 293:217–224.
  • Wu D. and Cederbaum A.I. (1994) Characterization of pyrazole and 4-methylpyrazole induction of cyto- chrome P4502E1 in rat kidney. Journal of Pharma- cology & Experimental Therapeutics 270:407–413.
  • Yonamine M., Aniya Y., Yokomakura T., Koyama T., Nagamine T. and Nakanishi H. (1996) Acetaminophen- derived activation of liver microsomal glutathione S-transferase of rats. Japanese Journal of Pharmacol- ogy 72:175–181.
  • Younes M., Cornelius S. and Siegers C.P. (1986) Ferrous iron supported in vivo lipid peroxidation induced by paracetamol, its relation to hepatotoxicity. Research Communications in Chem icalPathology and Phar- macology 51:89–99.
  • Younes M., Sause C., Siegers C.P. and Lemoine R. (1988) Effect of deferrioxamine and diethyldithiocarbamate on paracetamol-induced hepato- and nephrotoxicity. The role of lipid peroxidation. Journal of Applied Toxicology 8:261–265.
  • Zaher H., Buters J.T.M., Ward J.M., Bruno M.K., Lucas A.M., Stern S.T., S.D. C. and Gonzalez F.J. (1998) Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicology and Ap- plied Pharmacology 152:193–199.
  • Zand R., Nelson S.D., Slattery J.T., Thummel K.E., Kalhorn T.F., Adams S.P. and Wright J.M. (1993) Inhibition and induction of cytochrome P4502E1–catalyzed oxi- dation by isoniazid in humans. Clinical Pharmacol- ogy & Therapeutics 54:142–149.
  • Zhou L., Erickson R.R., Hardwick J.P., Park S.S., Wrighton S.A. and Holtzman J.L. (1997a) Catalysis of the cys- teine conjugation and protein binding of acetaminophen by microsomes from a human lymphoblast line trans- fected with the cDNAs of various forms of human cytochrome P450. Journal of Pharmacology and Ex- perimental Therapeutics 281:785–790.
  • Zhou L., McKenzie B.A., Eccleston E.D., Jr., Srivastava S.P., Chen N., Erickson R.R. and Holtzman J.L. (1996) The covalent binding of [14C]acetaminophen to mouse hepatic microsomal proteins: the specific binding to calreticulin and the two forms of the thiol: proteindisulfide oxidoreductases. Chemical Research in Toxi- cology 9:1176–1182.
  • Zhou L.X., Erickson R.R. and Holtzman J.L. (1997b) Stud- ies comparing the kinetics of cysteine conjugation and protein binding of acetaminophen by hepatic mi- crosomes from male mice. Biochimica et Biophysica Acta 1335:153–160.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.